Training Centers

We are proud to partner with several leading cardiovascular centers across the United States to educate interventionalists on the clinical applications and value of robotic PCI. Training centers include:


Course Proctors


Dr. Paul T. Campbell is an interventional cardiologist with the Sanger Heart & Vascular Institute. He has more than 25 years of experience in the field at the Carolinas Healthcare System NorthEast (CHS-NE). His main research interests are robotics in cardiovascular interventions and radiation safety in the cath lab. He trained in medicine and cardiology at Duke University and he is a member of the Duke University Cooperative Cardiovascular Society. He is a fellow of The Society for Cardiovascular Angiography and Interventions and the American College of Cardiology.

The Sanger Heart & Vascular Institute, part of Carolinas Healthcare System, encompasses more than 175 providers and 20 Care Centers across the Carolinas. Carolinas HealthCare System NorthEast is a 500-bed, acute-care teaching hospital located in Concord, North Carolina, which serves as a primary percutaneous coronary intervention (PCI) center as well as a tertiary referral hospital for ST-elevation myocardial infarction. With more than 20 cardiologists/cardiac advanced care providers the cath labs perform approximately 2,000 catheterizations per year and 1,200 PCIs annually. Procedures include diagnostic left and right heart catheterizations, PCI, robotic PCI, rotational coronary atherectomy, intravascular ultrasound, fractional flow reserve, optical coherence tomography, hemodynamic support with Impella (Abiomed), intra-aortic balloon pump placement, pericardiocentesis as well as peripheral angiography and interventions including endovascular aneurysm repair in a hybrid room.

CHS-NE's robotic program began in 2013 with the 1st generation CorPath 200 System. The program has since evolved with an upgrade to the second generation CorPath GRX System. Dr. Campbell has been actively involved in the PRECISION registry and has published several articles relating to his work around stent savings with robotics, the use of the robotic system for precise measurement, and robotics for the reduction of staff radiation exposure.

The use of robotic coronary intervention was instituted to improve precision, accuracy, control and safety. The CorPath GRX System allows for successful complex robotic PCI with precise measurement, controlled device movements, constant fixation of devices, enhanced visualization, reduced radiation and improved ergonomics. Moreover, the addition of this innovative technology to our cath lab has increased the technical skills of the staff, improved staff morale and led to enhanced teamwork at CHS-NE.


William Lombardi, M.D., is a board certified cardiologist at UW Medical Center and Northwest Hospital, director of Complex Coronary Artery Disease Therapies in the Regional Heart Center Cardiology Clinic and a UW associate professor of Cardiology. Dr. Lombardi is an expert in cardiac catheterization and interventional cardiology. He strives to create active partnerships with his patients to achieve the best possible outcomes.

Dr. Lombardi started his robotic program in 2018 with the CorPath GRX System. He is also a member of the Corindus Steering Committee and partners with the company on clinical initiatives and to support the development of future robotic technologies.

Dr. Lombardi earned his M.D. at Tulane University, New Orleans. He is board certified in both Interventional Cardiology and Cardiovascular Disease. His clinical interests include interventional cardiology and cardiac catheterization. He has focused much of his research efforts on developing and refining coronary chronic total occlusions and complex coronary artery procedures with great efficacy and reproducibility.


Dr. Manish A. Parikh, MD, FACC is the Associate Director of the Cardiac Catheterization Laboratory at the College of Physicians and Surgeons at Columbia University and the Director of Business Development at the Center for Interventional Vascular Therapy.

Dr. Parikh received his medical degree from UMDNJ in New Jersey and trained at The New York Hospital-Cornell University Medical Center in New York. Dr. Parikh specializes in complex coronary interventions and is a leader in medical education for the field.

NewYork-Presbyterian was one of nine clinical sites involved in the pivotal PRECISE Trial in 2011, which won the first generation CorPath 200 System FDA 510(k) clearance. The hospital then began performing robotic-assisted PCI regularly in 2012 with the CorPath 200 System. In early 2017, NYP was one of the first three hospitals to install and perform procedures using the second generation CorPath GRX System. Today, Dr. Parikh is the course proctor for Robotic Skills Labs taking place regularly in New York.


Srini Potluri, MD, FACC joined The Heart Hospital Baylor Plano from the Ochsner Clinic Foundation in New Orleans, Louisiana where he was Chief Interventional Fellow and was on the Foundation’s interventional staff. He completed fellowships in cardiology, interventional cardiology and heart failure and cardiac transplantation at the Ochsner Clinic Foundation as well.

He serves as the medical director of the catheterization laboratory at The Heart Hospital Baylor Plano and head of the Legacy Heart Center Vein and Vascular Clinic. Dr. Potluri is board certified by the American Board of Internal Medicine in Cardiovascular Disease and Interventional Cardiology.

THHBP launched their robotic program with the first generation CorPath 200 System in late 2016 and has since upgraded to the second generation CorPath GRX System which is installed in 2 of their cath labs. THHBP is actively involved in clinical research on robotic-assisted PCI and Dr. Potluri enrolled the first patient in the PRECISION GRX Registry, a post market study to continue market surveillance of CorPath GRX.


Dr. Michael Ragosta is board certified in Internal Medicine, Cardiovascular diseases and Interventional cardiology. He specializes in Interventional Cardiology with an interest in complex coronary artery disease, chronic total occlusion and heart valve disease.

Dr. Ragosta has been principal investigator or co-principal investigator in numerous multicenter clinical trials involving coronary artery disease, coronary interventional therapy, valvular heart disease and coronary physiology. He has shared his research and experience through more than 40 invited lectures or visiting professorships and by authoring or co-authoring more than 120 peer-reviewed journal publications, books, book chapters and scientific abstracts. Dr. Ragosta is Medical Director for Interventional Cardiology at UVA.

UVA launched their robotic program in 2014 with the first generation CorPath 200 System. In 2017, UVA was one of the first three hospitals to install and perform procedures with the second generation CorPath GRX System.


Alpesh Shah M.D., FACC, FSCAI is an Interventional Cardiologist and Associate Professor at Houston Methodist Hospital. He is also faculty with Weill Cornell Medicine and Baylor College of Medicine and remains involved training Medical residents and cardiology Fellows.

Dr. Shah was born In India, and after finishing Medical School at Baroda Medical College in 1993, immigrated to USA to pursue advanced medical education and research. He did his Internal Medicine residency at Jacobi Medical Center with Albert Einstein Medical College in NewYork from 1993 to 1996. He did his General Cardiology fellowship at St. Vincent’s Hospital with NewYork Medical College in NewYork from 1996 to 1999. He moved to Houston and did Interventional Cardiology Fellowship at Methodist Hospital with Baylor College of Medicine from 1999 to 2000.

Dr. Shah performs a wide array of Interventional Cardiology procedures with expertise in complex coronary interventions such as chronic total occlusion, coronary brachytherapy for restenosis, carotid artery stenting, and novel stent implants. He also has spearheaded the robotic assisted vascular intervention program in the Cardiac catheterization lab. Dr. Shah and the team at Houston Methodist launched their robotic-assisted PCI program with the CorPath GRX System in September 2017, becoming the newest training center. Physicians attending courses at Houston Methodist will participate in didactic education, live case observation led by Dr. Shah, and a unique workshop for a hands-on introduction to robotic-assisted PCI which takes place in the state-of-the-art Houston Methodist Institute for Technology, Innovation & Education (MITIESM).


Dr. Kanwar Singh is board certified in Cardiovascular Disease and Interventional Cardiology. His research interests are centered on the evaluation and application of novel therapeutic devices and medical strategies employed in the Cath Lab. Dr. Singh received his medical degree from McGill University and trained at Brigham and Women's Hospital and Duke University.

UVA launched their robotic program in 2014 with the first generation CorPath 200 System. In 2017, UVA was one of the first three hospitals to install and perform procedures with the second generation CorPath GRX System.


Dr. Frances Wood is a board certified interventional and structural cardiologist, specializing in complex coronary interventions and valvular disease. She is the Cardiology Director of Structural Heart at WakeMed. Dr. Wood received her medical degree from Eastern Virginia Medical School, completed her residency at University of Texas Southwestern Medical Center, and completed multiple fellowships at William Beaumont Hospital.

In additional to interventional training, she spent a focused year on structural cardiovascular services and brings expertise in advanced imaging and procedures such as: valve replacement (TAVR), mitral valve repair (MitraClip), atrial septal defect/patent foramen ovale closure, alcohol septal ablation, left atrial appendage occlusion, percutaneous balloon mitral valvuloplasty and paravalvular leak closure.

WakeMed launched their robotic program with the installation of three CorPath GRX Systems in May 2017. Dr. Wood is the Robotic Program Director for the hospital.